Brian Piekos insider trades

Open-market stock purchases and sales by Brian Piekos, Chief Financial Officer at KalVista Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 16, 2020.

Recent trades

DateStockTradeValue
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)$1.2M
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
May 22, 2026KALV KalVista Pharmaceuticals, IncSold$39.9K
May 21, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Apr 17, 2026KALV KalVista Pharmaceuticals, IncSold$37.6K
Apr 16, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Feb 23, 2026KALV KalVista Pharmaceuticals, IncSold$27.5K
Feb 21, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Jan 16, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Nov 24, 2025KALV KalVista Pharmaceuticals, IncSold$60.1K
Nov 21, 2025KALV KalVista Pharmaceuticals, IncBought (not open market)—

Companies traded

  • KALV KalVista Pharmaceuticals, Inc: 4 sales, last Jun 11, 2026
  • ELTX Elicio Therapeutics, Inc: other filings, last Feb 1, 2024
  • GMTX Gemini Therapeutics, Inc /DE: 1 buy, last May 31, 2022
  • AMAG Amag Pharmaceuticals, Inc: other filings, last Nov 16, 2020

Get free alerts when Brian Piekos files a new trade →